3 Trademark Results found for "THERADIGM*"

Also try searching for:

THER*

*IGM

TH*GM

Details	Status	Class/Description
THERADIGM THERADIGM INC. 1896261 27 Apr 2018	REGISTERED on 8 Dec 2021	Biologics, namely cells and cell lines for use in the development, tes... Class 001 Class 001 Chemical Products Biologics, namely cells and cell lines for use in the development, testing and manufacture of therapeutics; biologics, namely cells and cell lines for use in the production of biologic substances, namely, growth factors and proteins; biologics, namely cells and cell lines for the testing of chemical substances; stem cells and progenitor cells for use in the development, testing and manufacture of therapeutics; stem cells and progenitor cells for the testing of chemical substances; bone marrow stromal cells (BMSCs) for use in the development, testing and manufacture of therapeutics; bone marrow stromal cells (BMSCs) for use in the production of biologic substances, namely, growth factors and proteins; bone marrow stromal cells (BMSCs) for the testing of chemical substances; adipose tissue stromal cells (ASCs) for use in the development, testing and manufacture of therapeutics; adipose tissue stromal cells (ASCs) for use in the production of biologic substances, namely, growth factors and proteins; adipose tissue stromal cells (ASCs) for the testing of chemical substances Class 005 Class 005 Pharmaceutical Products Biologics, namely cells and cell lines for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, particularly against pathogens or cancers, or to modulate the immune system, particularly against auto-immune disease or inflammatory conditions; stem cells and progenitor cells for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, particularly against pathogens or cancers, or to modulate the immune system, particularly against auto-immune disease or inflammatory conditions; bone marrow stromal cells (BMSCs) for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, particularly against pathogens or cancers, or to modulate the immune system, particularly against auto-immune disease or inflammatory conditions; adipose tissue stromal cells (ASCs) for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, particularly against pathogens or cancers, or to modulate the immune system, particularly against auto-immune disease or inflammatory conditions; cell growth media consisting of biological materials for growing cells for medical purposes; stem cells and progenitor cells for use in the production of biologic substances, namely, growth factors and proteins for medical purposes; proteins for medical use, namely, protein arrays for medical diagnosis purposes; synthetic peptides for medical purposes, namely, the treatment of neuro-degenerative disorders, metabolic disorders, inflammatory and auto-immune disorders, orthopedic disorders, heart and vasculature disorders, and cancer; small molecules for medical purposes, namely, clinical diagnostic reagents; telomerase activators (agonists) and inhibitors (antagonists) for use as medicinal products; cell-based therapeutics for the treatment of central nervous system (CNS) disorders, de-myelinating disorders, auto-immune disorders, peripheral neural disorders, namely, Guillain-Barre Strohl Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy (CIPD), Diabetic Neuropathy, Peripheral Nerve Injuries, Radiculopathies, and Small Fiber Neuropathies, and autism; Cell-based therapeutics for the treatment of stroke, spinal cord injury, brain injury, brain tumours, Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig's Disease), Parkinson's disease, Huntington's disease, Multiple Sclerosis (MS), and MS-like diseases with the following symptoms: cognitive dysfunction, mobility dysfunction, and neurological disorders; Pharmaceutical preparations for the treatment of the central nervous system (CNS), namely stroke, spinal cord injury, brain injury, brain tumours, amyotrophic lateral sclerosis (ALS) (Lou Gehrig's Disease), Parkinson's disease, Huntington's disease, multiple sclerosis (MS), and cognitive dysfunction, mobility dysfunction, and neurological disorders, peripheral neural disorders, namely, Guillain-Barre Strohl Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy (CIPD), Diabetic Neuropathy, Peripheral Nerve Injuries, Radiculopathies, and Small Fiber Neuropathies, and autism ... Class 042 Computer & Software Services & Scientific Services Pharmaceutical research and development; biological research and development; medical research and development in the field of regenerative medicine and immunotherapies; consultation and research in the field of stem and progenitor cells and bone marrow stromal cells and adipose tissue stromal cells; consultation and research in the field of central nervous system (CNS) disorders; consultation and research in the field of stroke, spinal cord injury, brain injury, brain tumours, amyotrophic lateral sclerosis (ALS) (Lou Gehrig's Disease), Parkinson's Disease, Huntington's Disease, multiple sclerosis (MS), and MS-like diseases, namely, fibromyalgia, vitamin B12 deficiency, muscular dystrophy (MD), hypo-thyroidism, hypertension, and Arnold-Chiari deformity, peripheral neural disorders, namely, Guillain-Barre Strohl Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy (CIPD), Diabetic Neuropathy, Peripheral Nerve Injuries, Radiculopathies, and Small Fiber Neuropathies, and autism; research and development of cell-based therapies for neurological and central nervous system (CNS) injuries and disorders, de-myelinating disorders, auto-immune disorders, peripheral neural disorders, namely, Guillain-Barre Strohl Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy (CIPD), Diabetic Neuropathy, Peripheral Nerve Injuries, Radiculopathies, and Small Fiber Neuropathies, and autism; contract manufacturing of biologics, cells, and cell lines for others for medical use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system against pathogens or cancers, or to modulate the immune system against autoimmune disease or inflammatory conditions; contract manufacturing of biological materials for others for medical purposes, namely, biological cell and tissue cultures Class 044 Medical, Beauty & Agricultural Services Medical treatment services in the field of regenerative medicine and immunotherapies; medical services for the treatment of central nervous system (CNS) disorders; medical services for the treatment of stroke, spinal cord injury, brain injury, brain tumours, amyotrophic lateral sclerosis (ALS) (Lou Gehrig's Disease), Parkinson's Disease, Huntington's Disease, multiple sclerosis (MS), and MS-like diseases, namely, fibromyalgia, vitamin B12 deficiency, muscular dystrophy (MD), hypo-thyroidism, hypertension, and Arnold- Chiari deformity, peripheral neural disorders, namely, Guillain-Barre Strohl Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy (CIPD), Diabetic Neuropathy, Peripheral Nerve Injuries, Radiculopathies, and Small Fiber Neuropathies, and autism; medical treatment services, namely, using cell-based therapies for the treatment of neurological and central nervous system (CNS) injuries and disorders, de-myelinating disorders, auto-immune disorders, peripheral neural disorders, namely, Guillain-Barre Strohl Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy (CIPD), Diabetic Neuropathy, Peripheral Nerve Injuries, Radiculopathies, and Small Fiber Neuropathies, and autism
THERADIGM THERADIGM INC. 1547217 11 Oct 2011	ABANDONED SECTION 40(3) on 23 May 2018	(1) Biologics, namely Cells and cell lines for use as therapeutics to ... Class 001 Class 001 Chemical Products (1) Biologics, namely Cells and cell lines for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, including against pathogens or cancers, or to modulate the immune system, including against auto-immune disease or inflammatory conditions (2) Stem cells and progenitor cells for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, including against pathogens or cancers, or to modulate the immune system, including against auto-immune disease or inflammatory conditions (3) Bone Marrow Stromal Cells (BMSCs) for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, including against pathogens or cancers, or to modulate the immune system, including against auto-immune disease or inflammatory conditions (4) Adipose tissue stromal cells (ASCs) for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, including against pathogens or cancers, or to modulate the immune system, including against auto-immune disease or inflammatory conditions (5) Growth factors for use as medicinal products (6) Proteins for use as medicinal products (7) Peptides for use as medicinal products , (8) Small molecules for use as medicinal products , (9) Telomerase activators (agonists) and inhibitors (antagonists) for use as medicinal products (10) Cell-based therapeutics for the treatment of Central Nervous System (CNS) disorders, de-myelinating disorders, auto-immune disorders, peripheral neural disorders, and autism (11) Cell-based therapeutics for the treatment of stroke, spinal cord injury, brain injury, brain tumours, Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig's Disease), Parkinson's disease, Huntington's disease, peripheral neural disorders, autism, Multiple Sclerosis (MS), and MS-like diseases with the following symptoms: cognitive dysfunction, mobility dysfunction, and neurological disorders (12) Pharmaceutical preparations for the treatment of the Central Nervous System (CNS), namely stroke, spinal cord injury, brain injury, brain tumours, Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig's Disease), Parkinson's disease, Huntington's disease, Multiple Sclerosis (MS), and cognitive dysfunction, mobility dysfunction, and neurological disorders, peripheral neural disorders, and autism (13) Biologics, namely Cells and cell lines for use in the development, testing and manufacture of therapeutics (14) Biologics, namely Cells and cell lines for use in the production of biologic substances, including growth factors and proteins , (15) Biologics, namely Cells and cell lines for the testing of chemical substances (16) Stem cells and progenitor cells for use in the development, testing and manufacture of therapeutics (17) Stem cells and progenitor cells for use in the production of biologic substances, including growth factors and proteins (18) Stem cells and progenitor cells for the testing of chemical substances , (19) Bone Marrow Stromal Cells (BMSCs) for use in the development, testing and manufacture of therapeutics (20) Bone Marrow Stromal Cells (BMSCs) for use in the production of biologic substances, including growth factors and proteins (21) Bone Marrow Stromal Cells (BMSCs) for the testing of chemical substances (22) Adipose tissue stromal cells (ASCs) for use in the development, testing and manufacture of therapeutics (23) Adipose tissue stromal cells (ASCs) for use in the production of biologic substances, including growth factors and proteins (24) Adipose tissue stromal cells (ASCs) for the testing of chemical substances. Class 005 Class 005 Pharmaceutical Products (1) Pharmaceutical research, development and medical treatment services (2) Biological research, development and medical treatment services (3) Medical research, development and medical treatment services (including regenerative medicine and immunotherapies) (4) Consultation, research and treatment in the field of stem and progenitor cells and bone marrow stromal cells and adipose tissue stromal cells (5) Consultation, research and treatment in the field of Central Nervous System (CNS) disorders , (6) Consultation, research and treatment in the field of stroke, spinal cord injury, brain injury, brain tumours, Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig's Disease), Parkinson's Disease, Huntington's Disease, Multiple Sclerosis (MS), and MS-like diseases, peripheral neural disorders, and autism (7) Research and development of, and treatment with, cell-based therapies for the treatment of neurological and Central Nervous System (CNS) injuries and disorders, de-myelinating disorders, auto-immune disorders, peripheral neural disorders, and autism (8) Manufacturing of biologics, cells, scaffolds and matrices, and related biological materials. ... Class 040 Treatment & Processing of Materials Services Class 042 Computer & Software Services & Scientific Services Class 044 Medical, Beauty & Agricultural Services
THERADIGM THERADIGM CORPORATION 1174306 22 Apr 2003	ABANDONED SECTION 40(3) on 26 Oct 2011	Performance of research services in the development of cellular produc... Class 042 Class 042 Computer & Software Services & Scientific Services Performance of research services in the development of cellular products in the field of neural cell implants

REGISTERED

on 8 Dec 2021

THERADIGM

THERADIGM INC.

1896261 · 27 Apr 2018

001

005

Class 005

Pharmaceutical Products

Biologics, namely cells and cell lines for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, particularly against pathogens or cancers, or to modulate the immune system, particularly against auto-immune disease or inflammatory conditions; stem cells and progenitor cells for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, particularly against pathogens or cancers, or to modulate the immune system, particularly against auto-immune disease or inflammatory conditions; bone marrow stromal cells (BMSCs) for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, particularly against pathogens or cancers, or to modulate the immune system, particularly against auto-immune disease or inflammatory conditions; adipose tissue stromal cells (ASCs) for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, particularly against pathogens or cancers, or to modulate the immune system, particularly against auto-immune disease or inflammatory conditions; cell growth media consisting of biological materials for growing cells for medical purposes; stem cells and progenitor cells for use in the production of biologic substances, namely, growth factors and proteins for medical purposes; proteins for medical use, namely, protein arrays for medical diagnosis purposes; synthetic peptides for medical purposes, namely, the treatment of neuro-degenerative disorders, metabolic disorders, inflammatory and auto-immune disorders, orthopedic disorders, heart and vasculature disorders, and cancer; small molecules for medical purposes, namely, clinical diagnostic reagents; telomerase activators (agonists) and inhibitors (antagonists) for use as medicinal products; cell-based therapeutics for the treatment of central nervous system (CNS) disorders, de-myelinating disorders, auto-immune disorders, peripheral neural disorders, namely, Guillain-Barre Strohl Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy (CIPD), Diabetic Neuropathy, Peripheral Nerve Injuries, Radiculopathies, and Small Fiber Neuropathies, and autism; Cell-based therapeutics for the treatment of stroke, spinal cord injury, brain injury, brain tumours, Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig's Disease), Parkinson's disease, Huntington's disease, Multiple Sclerosis (MS), and MS-like diseases with the following symptoms: cognitive dysfunction, mobility dysfunction, and neurological disorders; Pharmaceutical preparations for the treatment of the central nervous system (CNS), namely stroke, spinal cord injury, brain injury, brain tumours, amyotrophic lateral sclerosis (ALS) (Lou Gehrig's Disease), Parkinson's disease, Huntington's disease, multiple sclerosis (MS), and cognitive dysfunction, mobility dysfunction, and neurological disorders, peripheral neural disorders, namely, Guillain-Barre Strohl Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy (CIPD), Diabetic Neuropathy, Peripheral Nerve Injuries, Radiculopathies, and Small Fiber Neuropathies, and autism

...

Class 042

Computer & Software Services & Scientific Services

Pharmaceutical research and development; biological research and development; medical research and development in the field of regenerative medicine and immunotherapies; consultation and research in the field of stem and progenitor cells and bone marrow stromal cells and adipose tissue stromal cells; consultation and research in the field of central nervous system (CNS) disorders; consultation and research in the field of stroke, spinal cord injury, brain injury, brain tumours, amyotrophic lateral sclerosis (ALS) (Lou Gehrig's Disease), Parkinson's Disease, Huntington's Disease, multiple sclerosis (MS), and MS-like diseases, namely, fibromyalgia, vitamin B12 deficiency, muscular dystrophy (MD), hypo-thyroidism, hypertension, and Arnold-Chiari deformity, peripheral neural disorders, namely, Guillain-Barre Strohl Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy (CIPD), Diabetic Neuropathy, Peripheral Nerve Injuries, Radiculopathies, and Small Fiber Neuropathies, and autism; research and development of cell-based therapies for neurological and central nervous system (CNS) injuries and disorders, de-myelinating disorders, auto-immune disorders, peripheral neural disorders, namely, Guillain-Barre Strohl Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy (CIPD), Diabetic Neuropathy, Peripheral Nerve Injuries, Radiculopathies, and Small Fiber Neuropathies, and autism; contract manufacturing of biologics, cells, and cell lines for others for medical use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system against pathogens or cancers, or to modulate the immune system against autoimmune disease or inflammatory conditions; contract manufacturing of biological materials for others for medical purposes, namely, biological cell and tissue cultures

Class 044

Medical, Beauty & Agricultural Services

Medical treatment services in the field of regenerative medicine and immunotherapies; medical services for the treatment of central nervous system (CNS) disorders; medical services for the treatment of stroke, spinal cord injury, brain injury, brain tumours, amyotrophic lateral sclerosis (ALS) (Lou Gehrig's Disease), Parkinson's Disease, Huntington's Disease, multiple sclerosis (MS), and MS-like diseases, namely, fibromyalgia, vitamin B12 deficiency, muscular dystrophy (MD), hypo-thyroidism, hypertension, and Arnold- Chiari deformity, peripheral neural disorders, namely, Guillain-Barre Strohl Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy (CIPD), Diabetic Neuropathy, Peripheral Nerve Injuries, Radiculopathies, and Small Fiber Neuropathies, and autism; medical treatment services, namely, using cell-based therapies for the treatment of neurological and central nervous system (CNS) injuries and disorders, de-myelinating disorders, auto-immune disorders, peripheral neural disorders, namely, Guillain-Barre Strohl Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy (CIPD), Diabetic Neuropathy, Peripheral Nerve Injuries, Radiculopathies, and Small Fiber Neuropathies, and autism

Biologics, namely cells and cell lines for use in the development, tes...

ABANDONED SECTION 40(3)

on 23 May 2018

THERADIGM

THERADIGM INC.

1547217 · 11 Oct 2011

001

Class 001

Chemical Products

(1) Biologics, namely Cells and cell lines for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, including against pathogens or cancers, or to modulate the immune system, including against auto-immune disease or inflammatory conditions (2) Stem cells and progenitor cells for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, including against pathogens or cancers, or to modulate the immune system, including against auto-immune disease or inflammatory conditions (3) Bone Marrow Stromal Cells (BMSCs) for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, including against pathogens or cancers, or to modulate the immune system, including against auto-immune disease or inflammatory conditions (4) Adipose tissue stromal cells (ASCs) for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, including against pathogens or cancers, or to modulate the immune system, including against auto-immune disease or inflammatory conditions (5) Growth factors for use as medicinal products (6) Proteins for use as medicinal products (7) Peptides for use as medicinal products , (8) Small molecules for use as medicinal products , (9) Telomerase activators (agonists) and inhibitors (antagonists) for use as medicinal products (10) Cell-based therapeutics for the treatment of Central Nervous System (CNS) disorders, de-myelinating disorders, auto-immune disorders, peripheral neural disorders, and autism (11) Cell-based therapeutics for the treatment of stroke, spinal cord injury, brain injury, brain tumours, Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig's Disease), Parkinson's disease, Huntington's disease, peripheral neural disorders, autism, Multiple Sclerosis (MS), and MS-like diseases with the following symptoms: cognitive dysfunction, mobility dysfunction, and neurological disorders (12) Pharmaceutical preparations for the treatment of the Central Nervous System (CNS), namely stroke, spinal cord injury, brain injury, brain tumours, Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig's Disease), Parkinson's disease, Huntington's disease, Multiple Sclerosis (MS), and cognitive dysfunction, mobility dysfunction, and neurological disorders, peripheral neural disorders, and autism (13) Biologics, namely Cells and cell lines for use in the development, testing and manufacture of therapeutics (14) Biologics, namely Cells and cell lines for use in the production of biologic substances, including growth factors and proteins , (15) Biologics, namely Cells and cell lines for the testing of chemical substances (16) Stem cells and progenitor cells for use in the development, testing and manufacture of therapeutics (17) Stem cells and progenitor cells for use in the production of biologic substances, including growth factors and proteins (18) Stem cells and progenitor cells for the testing of chemical substances , (19) Bone Marrow Stromal Cells (BMSCs) for use in the development, testing and manufacture of therapeutics (20) Bone Marrow Stromal Cells (BMSCs) for use in the production of biologic substances, including growth factors and proteins (21) Bone Marrow Stromal Cells (BMSCs) for the testing of chemical substances (22) Adipose tissue stromal cells (ASCs) for use in the development, testing and manufacture of therapeutics (23) Adipose tissue stromal cells (ASCs) for use in the production of biologic substances, including growth factors and proteins (24) Adipose tissue stromal cells (ASCs) for the testing of chemical substances.

005

...

(1) Biologics, namely Cells and cell lines for use as therapeutics to ...

ABANDONED SECTION 40(3)

on 26 Oct 2011

THERADIGM

THERADIGM CORPORATION

1174306 · 22 Apr 2003

042

Performance of research services in the development of cellular produc...

Owners

Theradigm inc. (2)

Theradigm corporation (1)

Categories

Class 42 (3)

Class 1 (2)

Class 5 (2)

Class 44 (2)

Class 40 (1)

Correspondents

Dla piper (canada) llp (2)

Ledgley law (1)

Display

List View

Grid View

Apply for Trademark

Select countries to protect your logo Trademark

Trademark Name

Country Selected

Canada

C$500/ 1 class + gov fee

United States

C$137/ 1 class + gov fee

Canada

C$500/ 1 class + gov fee

Mexico

C$691/ 1 class + gov fee

European Union

C$969/ 1 class + gov fee

China

C$691/ 1 class + gov fee

South Korea

C$967/ 1 class + gov fee

Japan

C$1,106/ 1 class + gov fee

India

C$137/ 1 class + gov fee

United Kingdom

C$691/ 1 class + gov fee

Australia

C$414/ 1 class + gov fee

Israel

C$967/ 1 class + gov fee

United Arab Emirates

C$967/ 1 class + gov fee

New Zealand

C$967/ 1 class + gov fee

Brazil

C$691/ 1 class + gov fee

Taiwan

C$1,106/ 1 class + gov fee

Ukraine

C$1,106/ 1 class + gov fee

Indonesia

C$967/ 1 class + gov fee

South Africa

C$691/ 1 class + gov fee

Singapore

C$1,106/ 1 class + gov fee

Saudi Arabia

C$1,106/ 1 class + gov fee

Afghanistan

C$1,106/ 1 class + gov fee

Algeria

C$1,106/ 1 class + gov fee

Argentina

C$552/ 1 class + gov fee

Austria

C$1,244/ 1 class + gov fee

Bahrain

C$967/ 1 class + gov fee

Bangladesh

C$829/ 1 class + gov fee

Benelux

C$1,382/ 1 class + gov fee

Bhutan

C$1,244/ 1 class + gov fee

Bolivia

C$1,106/ 1 class + gov fee

Botswana

C$1,797/ 1 class + gov fee

British Virgin Islands

C$1,659/ 1 class + gov fee

Bulgaria

C$1,106/ 1 class + gov fee

Cambodia

C$1,106/ 1 class + gov fee

Chile

C$691/ 1 class + gov fee

Colombia

C$967/ 1 class + gov fee

Congo

C$1,659/ 1 class + gov fee

Costa Rica

C$1,244/ 1 class + gov fee

Croatia

C$1,244/ 1 class + gov fee

Cyprus

C$1,382/ 1 class + gov fee

Czech Republic

C$1,244/ 1 class + gov fee

Denmark

C$1,106/ 1 class + gov fee

Curacao

C$1,659/ 1 class + gov fee

Macau

C$967/ 1 class + gov fee

Dominican Republic

C$1,244/ 1 class + gov fee

Aruba

C$1,659/ 1 class + gov fee

Greenland

C$1,106/ 1 class + gov fee

Ecuador

C$1,106/ 1 class + gov fee

Egypt

C$967/ 1 class + gov fee

El Salvador

C$1,106/ 1 class + gov fee

Ethiopia

C$1,521/ 1 class + gov fee

France

C$1,244/ 1 class + gov fee

Gaza

C$1,106/ 1 class + gov fee

Germany

C$1,244/ 1 class + gov fee

Greece

C$1,106/ 1 class + gov fee

Guatemala

C$1,244/ 1 class + gov fee

Haiti

C$1,244/ 1 class + gov fee

Honduras

C$1,244/ 1 class + gov fee

Hong Kong (SAR)

C$1,244/ 1 class + gov fee

Hungary

C$1,521/ 1 class + gov fee

Iraq

C$2,074/ 1 class + gov fee

Italy

C$1,244/ 1 class + gov fee

Jordan

C$1,106/ 1 class + gov fee

Kazakhstan

C$1,106/ 1 class + gov fee

Kenya

C$1,244/ 1 class + gov fee

Kuwait

C$1,106/ 1 class + gov fee

Laos

C$967/ 1 class + gov fee

Lebanon

C$1,382/ 1 class + gov fee

Lesotho

C$1,659/ 1 class + gov fee

Libya

C$1,244/ 1 class + gov fee

Madrid Protocol (WIPO)

C$2,766/ 1 class + gov fee

Malawi

C$1,521/ 1 class + gov fee

Malaysia

C$967/ 1 class + gov fee

Maldives

C$1,382/ 1 class + gov fee

Morocco

C$1,382/ 1 class + gov fee

Mozambique

C$1,244/ 1 class + gov fee

Myanmar

C$1,106/ 1 class + gov fee

Namibia

C$1,106/ 1 class + gov fee

Nepal

C$967/ 1 class + gov fee

Nicaragua

C$1,244/ 1 class + gov fee

Norway

C$1,244/ 1 class + gov fee

Oman

C$1,521/ 1 class + gov fee

Pakistan

C$1,106/ 1 class + gov fee

Panama

C$1,244/ 1 class + gov fee

Paraguay

C$1,244/ 1 class + gov fee

Peru

C$1,106/ 1 class + gov fee

Philippines

C$1,244/ 1 class + gov fee

Poland

C$691/ 1 class + gov fee

Portugal

C$1,244/ 1 class + gov fee

Puerto Rico

C$1,244/ 1 class + gov fee

Qatar

C$1,106/ 1 class + gov fee

Romania

C$1,244/ 1 class + gov fee

Serbia

C$1,244/ 1 class + gov fee

Slovakia

C$1,244/ 1 class + gov fee

Spain

C$1,244/ 1 class + gov fee

Sri Lanka

C$967/ 1 class + gov fee

Swaziland

C$1,797/ 1 class + gov fee

Sweden

C$1,106/ 1 class + gov fee

Switzerland

C$1,244/ 1 class + gov fee

Thailand

C$1,106/ 1 class + gov fee

Tunisia

C$1,244/ 1 class + gov fee

Turkey

C$1,106/ 1 class + gov fee

Uganda

C$967/ 1 class + gov fee

United Republic of Tanzania

C$967/ 1 class + gov fee

Uruguay

C$1,106/ 1 class + gov fee

Venezuela

C$1,244/ 1 class + gov fee

Vietnam

C$1,106/ 1 class + gov fee

West Bank, Palestine

C$1,106/ 1 class + gov fee

Yemen

C$2,351/ 1 class + gov fee

Albania

C$1,244/ 1 class + gov fee

Andorra

C$1,244/ 1 class + gov fee

Angola

C$1,797/ 1 class + gov fee

Antigua and Barbuda

C$1,659/ 1 class + gov fee

Armenia

C$1,106/ 1 class + gov fee

Azerbaijan

C$1,106/ 1 class + gov fee

Bahamas

C$1,936/ 1 class + gov fee

Barbados

C$1,797/ 1 class + gov fee

Belgium

C$1,382/ 1 class + gov fee

Belize

C$1,797/ 1 class + gov fee

Benin

C$1,106/ 1 class + gov fee

Bosnia and Herzegovina

C$1,382/ 1 class + gov fee

Brunei

C$1,797/ 1 class + gov fee

Burkina Faso

C$1,106/ 1 class + gov fee

Burundi

C$1,659/ 1 class + gov fee

Cabo Verde

C$1,244/ 1 class + gov fee

Cameroon

C$1,106/ 1 class + gov fee

Central African Republic (CAR)

C$1,106/ 1 class + gov fee

Chad

C$1,106/ 1 class + gov fee

Comoros

C$1,106/ 1 class + gov fee

Cote d'Ivoire

C$1,106/ 1 class + gov fee

Czechia

C$1,382/ 1 class + gov fee

Djibouti

C$1,659/ 1 class + gov fee

Dominica

C$1,797/ 1 class + gov fee

Equatorial Guinea

C$1,106/ 1 class + gov fee

Eritrea

C$1,382/ 1 class + gov fee

Estonia

C$1,797/ 1 class + gov fee

Eswatini

C$1,797/ 1 class + gov fee

Fiji

C$1,244/ 1 class + gov fee

Finland

C$967/ 1 class + gov fee

Gabon

C$1,106/ 1 class + gov fee

Gambia

C$1,244/ 1 class + gov fee

Georgia

C$1,106/ 1 class + gov fee

Ghana

C$1,382/ 1 class + gov fee

Grenada

C$1,797/ 1 class + gov fee

Guinea

C$1,106/ 1 class + gov fee

Guinea-Bissau

C$1,106/ 1 class + gov fee

Guyana

C$1,797/ 1 class + gov fee

Iceland

C$1,797/ 1 class + gov fee

Ireland

C$1,244/ 1 class + gov fee

Jamaica

C$1,659/ 1 class + gov fee

Kiribati

C$1,382/ 1 class + gov fee

Kosovo

C$1,244/ 1 class + gov fee

Kyrgyzstan

C$1,244/ 1 class + gov fee

Latvia

C$967/ 1 class + gov fee

Liberia

C$1,382/ 1 class + gov fee

Liechtenstein

C$1,382/ 1 class + gov fee

Lithuania

C$967/ 1 class + gov fee

Luxembourg

C$1,382/ 1 class + gov fee

Madagascar

C$1,382/ 1 class + gov fee

Mali

C$1,106/ 1 class + gov fee

Malta

C$829/ 1 class + gov fee

Marshall Islands

C$1,382/ 1 class + gov fee

Mauritania

C$1,106/ 1 class + gov fee

Mauritius

C$1,382/ 1 class + gov fee

Micronesia

C$1,382/ 1 class + gov fee

Moldova

C$1,382/ 1 class + gov fee

Monaco

C$1,936/ 1 class + gov fee

Mongolia

C$829/ 1 class + gov fee

Montenegro

C$1,244/ 1 class + gov fee

Nauru

C$1,382/ 1 class + gov fee

Netherlands

C$1,382/ 1 class + gov fee

Niger

C$1,106/ 1 class + gov fee

Nigeria

C$552/ 1 class + gov fee

North Macedonia

C$1,244/ 1 class + gov fee

Palau

C$1,382/ 1 class + gov fee

Palestine

C$1,382/ 1 class + gov fee

Papua New Guinea

C$1,106/ 1 class + gov fee

Rwanda

C$1,382/ 1 class + gov fee

Saint Kitts and Nevis

C$1,797/ 1 class + gov fee

Saint Lucia

C$1,797/ 1 class + gov fee

Saint Vincent and the Grenadines

C$1,797/ 1 class + gov fee

Samoa

C$1,659/ 1 class + gov fee

San Marino

C$1,382/ 1 class + gov fee

Sao Tome and Principe

C$1,382/ 1 class + gov fee

Senegal

C$1,106/ 1 class + gov fee

Seychelles

C$1,382/ 1 class + gov fee

Sierra Leone

C$1,382/ 1 class + gov fee

Slovenia

C$1,244/ 1 class + gov fee

Solomon Islands

C$1,382/ 1 class + gov fee

Somalia

C$1,382/ 1 class + gov fee

South Sudan

C$1,382/ 1 class + gov fee

Suriname

C$2,212/ 1 class + gov fee

Tajikistan

C$1,106/ 1 class + gov fee

Tanzania

C$967/ 1 class + gov fee

Timor-Leste

C$1,382/ 1 class + gov fee

Togo

C$1,106/ 1 class + gov fee

Tonga

C$1,797/ 1 class + gov fee

Trinidad and Tobago

C$1,659/ 1 class + gov fee

Turkmenistan

C$1,106/ 1 class + gov fee

Tuvalu

C$1,382/ 1 class + gov fee

Uzbekistan

C$967/ 1 class + gov fee

Vanuatu

C$1,659/ 1 class + gov fee

Zambia

C$1,244/ 1 class + gov fee

Zimbabwe

C$1,244/ 1 class + gov fee

OAPI

C$1,244/ 1 class + gov fee

ARIPO

C$1,382/ 1 class + gov fee

End of search results

Page 1 of 1